SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 32 filers reported holding SINOVAC BIOTECH LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,537 | 0.0% | 2,375,841 | 0.0% | 0.00% | +50.0% |
Q2 2023 | $1,537 | -99.9% | 2,375,841 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $1,537,000 | 0.0% | 2,375,841 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,537,000 | 0.0% | 2,375,841 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,537,000 | 0.0% | 2,375,841 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,537,000 | 0.0% | 2,375,841 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,537,000 | 0.0% | 2,375,841 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $1,537,000 | 0.0% | 2,375,841 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,537,000 | 0.0% | 2,375,841 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,537,000 | 0.0% | 2,375,841 | 0.0% | 0.00% | +100.0% |
Q2 2020 | $1,537,000 | 0.0% | 2,375,841 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $1,537,000 | 0.0% | 2,375,841 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $1,537,000 | -90.0% | 2,375,841 | 0.0% | 0.00% | -92.3% |
Q3 2019 | $15,372,000 | 0.0% | 2,375,841 | 0.0% | 0.01% | -7.1% |
Q2 2019 | $15,372,000 | 0.0% | 2,375,841 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $15,372,000 | -7.3% | 2,375,841 | -0.5% | 0.01% | -22.2% |
Q4 2018 | $16,577,000 | -11.1% | 2,388,573 | -2.4% | 0.02% | -5.3% |
Q3 2018 | $18,656,000 | -55.2% | 2,448,276 | -52.7% | 0.02% | -17.4% |
Q2 2018 | $41,625,000 | +83.2% | 5,172,930 | +96.0% | 0.02% | -8.0% |
Q1 2018 | $22,726,000 | +7.3% | 2,639,500 | -1.8% | 0.02% | +8.7% |
Q4 2017 | $21,177,000 | +38.4% | 2,687,400 | +23.8% | 0.02% | +27.8% |
Q3 2017 | $15,300,000 | +24.9% | 2,170,200 | +19.6% | 0.02% | +12.5% |
Q2 2017 | $12,247,000 | +27.3% | 1,814,300 | +8.0% | 0.02% | +23.1% |
Q1 2017 | $9,623,000 | +7.0% | 1,679,490 | +10.1% | 0.01% | -7.1% |
Q4 2016 | $8,996,000 | +3.4% | 1,524,800 | +3.4% | 0.01% | -6.7% |
Q3 2016 | $8,703,000 | +5.1% | 1,475,000 | +5.7% | 0.02% | -6.2% |
Q2 2016 | $8,279,000 | -2.9% | 1,396,100 | +4.6% | 0.02% | 0.0% |
Q1 2016 | $8,528,000 | +10.1% | 1,334,600 | -1.4% | 0.02% | -5.9% |
Q4 2015 | $7,745,000 | +17.9% | 1,354,100 | +4.7% | 0.02% | +6.2% |
Q3 2015 | $6,567,000 | -1.0% | 1,292,779 | +2.3% | 0.02% | +6.7% |
Q2 2015 | $6,632,000 | +12.7% | 1,263,200 | +6.5% | 0.02% | +15.4% |
Q1 2015 | $5,884,000 | -4.4% | 1,186,200 | +0.8% | 0.01% | -13.3% |
Q4 2014 | $6,152,000 | +1.0% | 1,176,362 | -7.1% | 0.02% | -11.8% |
Q3 2014 | $6,089,000 | -8.1% | 1,266,000 | +7.7% | 0.02% | +13.3% |
Q2 2014 | $6,627,000 | -10.8% | 1,175,000 | +13.9% | 0.02% | -16.7% |
Q1 2014 | $7,428,000 | +15.0% | 1,031,711 | -2.2% | 0.02% | +20.0% |
Q4 2013 | $6,457,000 | +20.4% | 1,054,996 | +17.7% | 0.02% | +15.4% |
Q3 2013 | $5,362,000 | +246.6% | 896,600 | +127.8% | 0.01% | +225.0% |
Q2 2013 | $1,547,000 | – | 393,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |